Donald A. Rowley

7.1k total citations
106 papers, 5.4k citations indexed

About

Donald A. Rowley is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Donald A. Rowley has authored 106 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 24 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Donald A. Rowley's work include Immunotherapy and Immune Responses (39 papers), Immune Cell Function and Interaction (30 papers) and T-cell and B-cell Immunology (29 papers). Donald A. Rowley is often cited by papers focused on Immunotherapy and Immune Responses (39 papers), Immune Cell Function and Interaction (30 papers) and T-cell and B-cell Immunology (29 papers). Donald A. Rowley collaborates with scholars based in United States, United Kingdom and Germany. Donald A. Rowley's co-authors include Hans Schreiber, Frank W. Fitch, Mary Philip, Earl P. Benditt, Michael T. Spiotto, Lynne V. Abruzzo, Yang‐Xin Fu, Heinz Köhler, Hartmut Koeppen and Bin Zhang and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Donald A. Rowley

104 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald A. Rowley United States 39 3.3k 1.9k 1.3k 653 409 106 5.4k
R B Herberman United States 41 5.3k 1.6× 1.5k 0.8× 1.1k 0.9× 898 1.4× 432 1.1× 176 7.2k
Howard T. Holden United States 35 4.8k 1.4× 1.3k 0.7× 1.2k 0.9× 765 1.2× 484 1.2× 95 6.6k
Tibor Diamantstein Germany 42 3.2k 1.0× 933 0.5× 1.2k 1.0× 607 0.9× 609 1.5× 189 5.0k
P Ralph United States 43 2.9k 0.9× 1.2k 0.6× 2.0k 1.6× 603 0.9× 543 1.3× 77 5.9k
Gianni Garotta Switzerland 43 3.4k 1.0× 1.6k 0.8× 1.3k 1.0× 601 0.9× 439 1.1× 112 5.5k
D Santoli United States 39 3.5k 1.1× 1.3k 0.7× 1.9k 1.5× 424 0.6× 629 1.5× 111 6.6k
R J Robb United States 43 5.7k 1.7× 1.3k 0.7× 1.8k 1.4× 1.4k 2.2× 426 1.0× 87 7.6k
M P Beckmann United States 33 3.8k 1.1× 1.7k 0.9× 1.9k 1.5× 640 1.0× 457 1.1× 44 6.9k
Gale A. Granger United States 34 3.4k 1.0× 945 0.5× 1.5k 1.2× 554 0.8× 311 0.8× 156 5.4k
Ronald Palacios Sweden 40 3.2k 1.0× 923 0.5× 1.5k 1.2× 838 1.3× 391 1.0× 100 5.1k

Countries citing papers authored by Donald A. Rowley

Since Specialization
Citations

This map shows the geographic impact of Donald A. Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald A. Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald A. Rowley more than expected).

Fields of papers citing papers by Donald A. Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald A. Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald A. Rowley. The network helps show where Donald A. Rowley may publish in the future.

Co-authorship network of co-authors of Donald A. Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of Donald A. Rowley. A scholar is included among the top collaborators of Donald A. Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald A. Rowley. Donald A. Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations
2.
Engels, Boris, Víctor H. Engelhard, John Sidney, et al.. (2013). Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity. Cancer Cell. 23(4). 516–526. 121 indexed citations
3.
Schreiber, Karin, Ainhoa Arina, Boris Engels, et al.. (2012). Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers. Clinical Cancer Research. 18(9). 2526–2533. 21 indexed citations
4.
Liu, Rebecca B., Boris Engels, Ainhoa Arina, et al.. (2012). Densely Granulated Murine NK Cells Eradicate Large Solid Tumors. Cancer Research. 72(8). 1964–1974. 45 indexed citations
5.
Rowley, Donald A. & Frank W. Fitch. (2012). The road to the discovery of dendritic cells, a tribute to Ralph Steinman. Cellular Immunology. 273(2). 95–98. 29 indexed citations
6.
Engels, Boris, Donald A. Rowley, & Hans Schreiber. (2011). Targeting stroma to treat cancers. Seminars in Cancer Biology. 22(1). 41–49. 62 indexed citations
7.
Zhang, Bin, Yi Zhang, Natalie A. Bowerman, et al.. (2008). Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma. Cancer Research. 68(5). 1563–1571. 59 indexed citations
8.
Zhang, Bin, Natalie A. Bowerman, Joseph K. Salama, et al.. (2007). Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. The Journal of Experimental Medicine. 204(1). 49–55. 299 indexed citations
9.
Yu, Ping, Donald A. Rowley, Yang‐Xin Fu, & Hans Schreiber. (2006). The role of stroma in immune recognition and destruction of well-established solid tumors. Current Opinion in Immunology. 18(2). 226–231. 89 indexed citations
10.
Schreiber, Hans, Terry Wu, James B. Nachman, & Donald A. Rowley. (2000). Immunological enhancement of primary tumor development and its prevention. Seminars in Cancer Biology. 10(5). 351–357. 30 indexed citations
11.
Blankenstein, Thomas, Donald A. Rowley, & Hans Schreiber. (1991). Cytokines and cancer: experimental systems. Current Opinion in Immunology. 3(5). 694–698. 44 indexed citations
12.
Schreiber, Hans, P L Ward, Donald A. Rowley, & Hans J. Stauss. (1988). Unique Tumor-Specific Antigens. Annual Review of Immunology. 6(1). 465–483. 68 indexed citations
13.
Rowley, Donald A., et al.. (1986). The immunological meaning of Thy-1-negative NK cells. Immunology Today. 7(7-8). 196–198. 4 indexed citations
14.
Mullen, Craig A., J L Urban, Carter Van Waes, Donald A. Rowley, & Hans Schreiber. (1985). Multiple cancers. Tumor burden permits the outgrowth of other cancers.. The Journal of Experimental Medicine. 162(5). 1665–1682. 64 indexed citations
15.
Strayer, David S., William M. F. Lee, Donald A. Rowley, & Heinz Köhler. (1975). Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 114(2 pt 2). 728–33. 54 indexed citations
16.
Rowley, Donald A., J. L. Gowans, R. C. Atkins, W. L. Ford, & Marilyn E. Smith. (1972). THE SPECIFIC SELECTION OF RECIRCULATING LYMPHOCYTES BY ANTIGEN IN NORMAL AND PREIMMUNIZED RATS. The Journal of Experimental Medicine. 136(3). 499–513. 116 indexed citations
17.
Rowley, Donald A. & Frank W. Fitch. (1964). HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT. The Journal of Experimental Medicine. 120(6). 987–1005. 130 indexed citations
18.
Rowley, Donald A.. (1963). Mast cell damage and vascular injury in the rat: an electron microscopic study of a reaction produced by thorotrast.. PubMed. 44. 284–90. 22 indexed citations
19.
Rowley, Donald A., et al.. (1962). Anemia produced in the rat by methylcellulose. I. Repeated intraperitoneal injections of methylcellulose.. PubMed. 74. 331–9. 5 indexed citations
20.
Benditt, Earl P. & Donald A. Rowley. (1956). Antagonism of 5-Hydroxytryptamine by Chlorpromazine. Science. 123(3184). 24–24. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R B Herberman Breakdown of academic impact, for papers by Howard T. Holden Breakdown of academic impact, for papers by Tibor Diamantstein Breakdown of academic impact, for papers by P Ralph Breakdown of academic impact, for papers by Gianni Garotta Breakdown of academic impact, for papers by D Santoli Breakdown of academic impact, for papers by R J Robb Breakdown of academic impact, for papers by M P Beckmann Breakdown of academic impact, for papers by Gale A. Granger Breakdown of academic impact, for papers by Ronald Palacios
Rankless by CCL
2026